Journal for ImmunoTherapy of Cancer (Nov 2023)
765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of the REVOLUTION trial
- Robert H Vonderheide,
- Andrew H Ko,
- Danny Khalil,
- Oliver Rosen,
- Robert A Wolff,
- James Francis,
- Samantha Bucktrout,
- Christopher R Cabanski,
- Silvia Boffo,
- Zev A Wainberg,
- Samik Upadhaya,
- Eileen M O’Reilly,
- Mark H O’Hara,
- George Fisher,
- Jamie Arnott,
- Ana Rosa Saez-Ibanez,
- Jay Campbell,
- Ute Dugan,
- Jill O’Donnell-Tormey
Affiliations
- Robert H Vonderheide
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Andrew H Ko
- 1University of California San Francisco, San Francisco, CA, USA
- Danny Khalil
- 1Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Oliver Rosen
- 11Akamis Bio, Cambridge, MA, USA
- Robert A Wolff
- Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- James Francis
- 10Akamis Bio, Abingdon, Oxfordshire, UK
- Samantha Bucktrout
- Parker Institute for Cancer Immunotherapy, San Francisco, California, USA
- Christopher R Cabanski
- 8Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- Silvia Boffo
- 3Bristol Myers Squibb, Princeton, NJ, USA
- Zev A Wainberg
- 13 Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
- Samik Upadhaya
- 8Cancer Research Institute, New York, NY, USA
- Eileen M O’Reilly
- 2Weill Cornell Medical College, New York, NY, USA
- Mark H O’Hara
- 2University of Pennsylvania, Philadelphia, PA, USA
- George Fisher
- 3Stanford University School of Medicine, Palo Alto, CA, USA
- Jamie Arnott
- 7Parker Institute for Cancer Immunotherapy, Chapel Hill, NC, USA
- Ana Rosa Saez-Ibanez
- 10Akamis Bio, Abingdon, Oxfordshire, UK
- Jay Campbell
- 9Cancer Research Institute, New York, NY, USA
- Ute Dugan
- 8Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA
- Jill O’Donnell-Tormey
- 9Cancer Research Institute, New York, NY, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0765
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.